Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Lymphoma, Non-Hodgkin (Disease Or Phenotype)

Omim:191170

Nci:C3211

Msh:D008228

Mondo:MONDO:18908

Medcin:MEDCIN:35839

Mdr:MDR:10029593

Id:674d7b65-4947-533d-a48d-94596c539139

Icpc2icd10eng:MTHU053464

Icd10cm:C85.9

Efo:EFO:5952

Doid:DOID:8538

Chv:CHV:7621

Results found

Linked to

	Label	Description
	Vincristine indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Mechlorethamine indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Betamethasone acetate indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	methylprednisolone indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fludarabine phosphate indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone Acetonide indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Dexamethasone indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisolone indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	triamcinolone indication Lymphoma, Non-Hodgkin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Vincristine indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Mechlorethamine indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Betamethasone acetate indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

methylprednisolone indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fludarabine phosphate indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone Acetonide indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Dexamethasone indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisolone indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

triamcinolone indication Lymphoma, Non-Hodgkin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.